img

Global Nocturnal Polyuria Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Nocturnal Polyuria Treatment Market Research Report 2024

According to MRAResearch’s new survey, global Nocturnal Polyuria Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nocturnal Polyuria Treatment market research.
Key companies engaged in the Nocturnal Polyuria Treatment industry include Allergan, Ferring Holding, Teva Pharmaceutical Industries, Urigen Pharmaceuticals, Vantia Therapeutics and Astellas Pharma, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Nocturnal Polyuria Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nocturnal Polyuria Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Nocturnal Polyuria Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Allergan
Ferring Holding
Teva Pharmaceutical Industries
Urigen Pharmaceuticals
Vantia Therapeutics
Astellas Pharma
Segment by Type
Antispasmodic
Desmopressin
Anticholinergic drugs
Other

Segment by Application


Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Nocturnal Polyuria Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nocturnal Polyuria Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Antispasmodic
1.2.3 Desmopressin
1.2.4 Anticholinergic drugs
1.2.5 Other
1.3 Market by Application
1.3.1 Global Nocturnal Polyuria Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nocturnal Polyuria Treatment Market Perspective (2018-2033)
2.2 Nocturnal Polyuria Treatment Growth Trends by Region
2.2.1 Global Nocturnal Polyuria Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Nocturnal Polyuria Treatment Historic Market Size by Region (2018-2023)
2.2.3 Nocturnal Polyuria Treatment Forecasted Market Size by Region (2024-2033)
2.3 Nocturnal Polyuria Treatment Market Dynamics
2.3.1 Nocturnal Polyuria Treatment Industry Trends
2.3.2 Nocturnal Polyuria Treatment Market Drivers
2.3.3 Nocturnal Polyuria Treatment Market Challenges
2.3.4 Nocturnal Polyuria Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nocturnal Polyuria Treatment Players by Revenue
3.1.1 Global Top Nocturnal Polyuria Treatment Players by Revenue (2018-2023)
3.1.2 Global Nocturnal Polyuria Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Nocturnal Polyuria Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nocturnal Polyuria Treatment Revenue
3.4 Global Nocturnal Polyuria Treatment Market Concentration Ratio
3.4.1 Global Nocturnal Polyuria Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nocturnal Polyuria Treatment Revenue in 2022
3.5 Nocturnal Polyuria Treatment Key Players Head office and Area Served
3.6 Key Players Nocturnal Polyuria Treatment Product Solution and Service
3.7 Date of Enter into Nocturnal Polyuria Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nocturnal Polyuria Treatment Breakdown Data by Type
4.1 Global Nocturnal Polyuria Treatment Historic Market Size by Type (2018-2023)
4.2 Global Nocturnal Polyuria Treatment Forecasted Market Size by Type (2024-2033)
5 Nocturnal Polyuria Treatment Breakdown Data by Application
5.1 Global Nocturnal Polyuria Treatment Historic Market Size by Application (2018-2023)
5.2 Global Nocturnal Polyuria Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Nocturnal Polyuria Treatment Market Size (2018-2033)
6.2 North America Nocturnal Polyuria Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Nocturnal Polyuria Treatment Market Size by Country (2018-2023)
6.4 North America Nocturnal Polyuria Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nocturnal Polyuria Treatment Market Size (2018-2033)
7.2 Europe Nocturnal Polyuria Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Nocturnal Polyuria Treatment Market Size by Country (2018-2023)
7.4 Europe Nocturnal Polyuria Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nocturnal Polyuria Treatment Market Size (2018-2033)
8.2 Asia-Pacific Nocturnal Polyuria Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Nocturnal Polyuria Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Nocturnal Polyuria Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nocturnal Polyuria Treatment Market Size (2018-2033)
9.2 Latin America Nocturnal Polyuria Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Nocturnal Polyuria Treatment Market Size by Country (2018-2023)
9.4 Latin America Nocturnal Polyuria Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nocturnal Polyuria Treatment Market Size (2018-2033)
10.2 Middle East & Africa Nocturnal Polyuria Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Nocturnal Polyuria Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Nocturnal Polyuria Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Nocturnal Polyuria Treatment Introduction
11.1.4 Allergan Revenue in Nocturnal Polyuria Treatment Business (2018-2023)
11.1.5 Allergan Recent Development
11.2 Ferring Holding
11.2.1 Ferring Holding Company Detail
11.2.2 Ferring Holding Business Overview
11.2.3 Ferring Holding Nocturnal Polyuria Treatment Introduction
11.2.4 Ferring Holding Revenue in Nocturnal Polyuria Treatment Business (2018-2023)
11.2.5 Ferring Holding Recent Development
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Detail
11.3.2 Teva Pharmaceutical Industries Business Overview
11.3.3 Teva Pharmaceutical Industries Nocturnal Polyuria Treatment Introduction
11.3.4 Teva Pharmaceutical Industries Revenue in Nocturnal Polyuria Treatment Business (2018-2023)
11.3.5 Teva Pharmaceutical Industries Recent Development
11.4 Urigen Pharmaceuticals
11.4.1 Urigen Pharmaceuticals Company Detail
11.4.2 Urigen Pharmaceuticals Business Overview
11.4.3 Urigen Pharmaceuticals Nocturnal Polyuria Treatment Introduction
11.4.4 Urigen Pharmaceuticals Revenue in Nocturnal Polyuria Treatment Business (2018-2023)
11.4.5 Urigen Pharmaceuticals Recent Development
11.5 Vantia Therapeutics
11.5.1 Vantia Therapeutics Company Detail
11.5.2 Vantia Therapeutics Business Overview
11.5.3 Vantia Therapeutics Nocturnal Polyuria Treatment Introduction
11.5.4 Vantia Therapeutics Revenue in Nocturnal Polyuria Treatment Business (2018-2023)
11.5.5 Vantia Therapeutics Recent Development
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Detail
11.6.2 Astellas Pharma Business Overview
11.6.3 Astellas Pharma Nocturnal Polyuria Treatment Introduction
11.6.4 Astellas Pharma Revenue in Nocturnal Polyuria Treatment Business (2018-2023)
11.6.5 Astellas Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Nocturnal Polyuria Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Antispasmodic
Table 3. Key Players of Desmopressin
Table 4. Key Players of Anticholinergic drugs
Table 5. Key Players of Other
Table 6. Global Nocturnal Polyuria Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Nocturnal Polyuria Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Nocturnal Polyuria Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Nocturnal Polyuria Treatment Market Share by Region (2018-2023)
Table 10. Global Nocturnal Polyuria Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Nocturnal Polyuria Treatment Market Share by Region (2024-2033)
Table 12. Nocturnal Polyuria Treatment Market Trends
Table 13. Nocturnal Polyuria Treatment Market Drivers
Table 14. Nocturnal Polyuria Treatment Market Challenges
Table 15. Nocturnal Polyuria Treatment Market Restraints
Table 16. Global Nocturnal Polyuria Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Nocturnal Polyuria Treatment Market Share by Players (2018-2023)
Table 18. Global Top Nocturnal Polyuria Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nocturnal Polyuria Treatment as of 2022)
Table 19. Ranking of Global Top Nocturnal Polyuria Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Nocturnal Polyuria Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Nocturnal Polyuria Treatment Product Solution and Service
Table 23. Date of Enter into Nocturnal Polyuria Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nocturnal Polyuria Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Nocturnal Polyuria Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global Nocturnal Polyuria Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Nocturnal Polyuria Treatment Revenue Market Share by Type (2024-2033)
Table 29. Global Nocturnal Polyuria Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Nocturnal Polyuria Treatment Revenue Market Share by Application (2018-2023)
Table 31. Global Nocturnal Polyuria Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Nocturnal Polyuria Treatment Revenue Market Share by Application (2024-2033)
Table 33. North America Nocturnal Polyuria Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Nocturnal Polyuria Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Nocturnal Polyuria Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Nocturnal Polyuria Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Nocturnal Polyuria Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Nocturnal Polyuria Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Nocturnal Polyuria Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Nocturnal Polyuria Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Nocturnal Polyuria Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Nocturnal Polyuria Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Nocturnal Polyuria Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Nocturnal Polyuria Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Nocturnal Polyuria Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Nocturnal Polyuria Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Nocturnal Polyuria Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 48. Allergan Company Detail
Table 49. Allergan Business Overview
Table 50. Allergan Nocturnal Polyuria Treatment Product
Table 51. Allergan Revenue in Nocturnal Polyuria Treatment Business (2018-2023) & (US$ Million)
Table 52. Allergan Recent Development
Table 53. Ferring Holding Company Detail
Table 54. Ferring Holding Business Overview
Table 55. Ferring Holding Nocturnal Polyuria Treatment Product
Table 56. Ferring Holding Revenue in Nocturnal Polyuria Treatment Business (2018-2023) & (US$ Million)
Table 57. Ferring Holding Recent Development
Table 58. Teva Pharmaceutical Industries Company Detail
Table 59. Teva Pharmaceutical Industries Business Overview
Table 60. Teva Pharmaceutical Industries Nocturnal Polyuria Treatment Product
Table 61. Teva Pharmaceutical Industries Revenue in Nocturnal Polyuria Treatment Business (2018-2023) & (US$ Million)
Table 62. Teva Pharmaceutical Industries Recent Development
Table 63. Urigen Pharmaceuticals Company Detail
Table 64. Urigen Pharmaceuticals Business Overview
Table 65. Urigen Pharmaceuticals Nocturnal Polyuria Treatment Product
Table 66. Urigen Pharmaceuticals Revenue in Nocturnal Polyuria Treatment Business (2018-2023) & (US$ Million)
Table 67. Urigen Pharmaceuticals Recent Development
Table 68. Vantia Therapeutics Company Detail
Table 69. Vantia Therapeutics Business Overview
Table 70. Vantia Therapeutics Nocturnal Polyuria Treatment Product
Table 71. Vantia Therapeutics Revenue in Nocturnal Polyuria Treatment Business (2018-2023) & (US$ Million)
Table 72. Vantia Therapeutics Recent Development
Table 73. Astellas Pharma Company Detail
Table 74. Astellas Pharma Business Overview
Table 75. Astellas Pharma Nocturnal Polyuria Treatment Product
Table 76. Astellas Pharma Revenue in Nocturnal Polyuria Treatment Business (2018-2023) & (US$ Million)
Table 77. Astellas Pharma Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nocturnal Polyuria Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Nocturnal Polyuria Treatment Market Share by Type: 2022 VS 2033
Figure 3. Antispasmodic Features
Figure 4. Desmopressin Features
Figure 5. Anticholinergic drugs Features
Figure 6. Other Features
Figure 7. Global Nocturnal Polyuria Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Nocturnal Polyuria Treatment Market Share by Application: 2022 VS 2033
Figure 9. Hospital Pharmacy Case Studies
Figure 10. Online Pharmacy Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Other Case Studies
Figure 13. Nocturnal Polyuria Treatment Report Years Considered
Figure 14. Global Nocturnal Polyuria Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Nocturnal Polyuria Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Nocturnal Polyuria Treatment Market Share by Region: 2022 VS 2033
Figure 17. Global Nocturnal Polyuria Treatment Market Share by Players in 2022
Figure 18. Global Top Nocturnal Polyuria Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nocturnal Polyuria Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Nocturnal Polyuria Treatment Revenue in 2022
Figure 20. North America Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Nocturnal Polyuria Treatment Market Share by Country (2018-2033)
Figure 22. United States Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Nocturnal Polyuria Treatment Market Share by Country (2018-2033)
Figure 26. Germany Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Nocturnal Polyuria Treatment Market Share by Region (2018-2033)
Figure 34. China Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Nocturnal Polyuria Treatment Market Share by Country (2018-2033)
Figure 42. Mexico Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Nocturnal Polyuria Treatment Market Share by Country (2018-2033)
Figure 46. Turkey Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Nocturnal Polyuria Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Allergan Revenue Growth Rate in Nocturnal Polyuria Treatment Business (2018-2023)
Figure 49. Ferring Holding Revenue Growth Rate in Nocturnal Polyuria Treatment Business (2018-2023)
Figure 50. Teva Pharmaceutical Industries Revenue Growth Rate in Nocturnal Polyuria Treatment Business (2018-2023)
Figure 51. Urigen Pharmaceuticals Revenue Growth Rate in Nocturnal Polyuria Treatment Business (2018-2023)
Figure 52. Vantia Therapeutics Revenue Growth Rate in Nocturnal Polyuria Treatment Business (2018-2023)
Figure 53. Astellas Pharma Revenue Growth Rate in Nocturnal Polyuria Treatment Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed